Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Miles Ingrey-CounterGeneral Counsel & Company Secretary | 1,04k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-05-15 | Mr. Andrew Gregory LewisInterim CFO | 2,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-05-15 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,08k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-04-14 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,00k | 31,23k | Kauf | 15,62 | 45,12k | 4,64% |
| 2026-01-05 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 9,34k | 0,00 | Derivative Exercise and Retained Stock | - | 43,12k | 27,64% |
| 2026-01-05 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | -8,34k | 145,84k | Derivative Exercise and Sale | 17,48 | 43,12k | - |
| 2026-01-05 | Mr. Dan ClarkGroup President of Simulation | 1,22k | 0,00 | Derivative Exercise and Retained Stock | - | 1,22k | - |
| 2026-01-05 | Mr. Dan ClarkGroup President of Simulation | -1,09k | 19,07k | Derivative Exercise and Sale | 17,48 | 1,22k | - |
| 2026-01-05 | Mr. Andrew NgGroup President of Testing Products | 2,95k | 0,00 | Derivative Exercise and Retained Stock | - | 2,95k | - |
| 2026-01-05 | Mr. Andrew NgGroup President of Testing Products | -2,64k | 46,08k | Derivative Exercise and Sale | 17,48 | 2,95k | - |
| 2026-01-05 | Mr. Matthew PriceGroup Corporate Development Director | 1,97k | 0,00 | Derivative Exercise and Retained Stock | - | 4,15k | 90,75% |
| 2026-01-05 | Mr. Matthew PriceGroup Corporate Development Director | -1,76k | 30,80k | Derivative Exercise and Sale | 17,48 | 4,15k | - |
| 2025-11-17 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 2,69k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 55,87k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Andrew NgGroup President of Testing Products | 16,99k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Matthew PriceGroup Corporate Development Director | 6,71k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Dan ClarkGroup President of Simulation | 11,68k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Neil CarpenterManaging Director of Testing Services | 8,83k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Ben RussellInsider | 9,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-17 | Mr. Rory GrunerudManaging Director of ABD Solutions | 8,76k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-09 | Ms. Sarah Louise Matthews-DeMersGroup CEO & Executive Director | 1.000,00 | 20,97k | Kauf | 20,97 | 31,09k | 3,32% |
| 2025-06-05 | Mr. Anthony BestInsider | -90,00k | 2,13M | Verkauf | 23,63 - 23,74 | 5,39M | -1,64% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
